[en] Health claims for food products in Europe are permitted if the nutrient has been shown to have a beneficial nutritional or physiological effect. This paper defines health claims related to bone health and provides guidelines for the design and the methodology of clinical studies to support claims.
Disciplines :
Public health, health care sciences & services General & internal medicine
Author, co-author :
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Rizzoli, René
Coxam, V.
Avouac, B.
Chevalier, T.
Fabien-Soulé, V.
Kanis, John A
Kaufman, Jean-Marc
Tsouderos, Yannis
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)
Publication date :
February 2012
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
Jones PJ, Asp NG, Silva P (2008) Evidence for health claims on foods: how much is enough? Introduction and general remarks. J Nutr 138:1189S-1191S (Pubitemid 351769150)
Grossklaus R (2009) Codex recommendations on the scientific basis of health claims. Eur J Nutr 48(Suppl 1):S15-S22
Asp NG, Bryngelsson S (2008) Health claims in Europe: new legislation and PASSCLAIM for substantiation. J Nutr 138:1210S-1215S (Pubitemid 351769153)
Prentice A, Bonjour JP, Branca F, Cooper C, Flynn A, Garabedian M, Muller D, Pannemans D, Weber P (2003) PASSCLAIM - bone health and osteoporosis. Eur J Nutr 42(Suppl 1):I28-I49
Rizzoli R (2008) Nutrition: its role in bone health. Best Pract Res Clin Endocrinol Metab 22:813-829
Rizzoli R, Bianchi ML, Garabedian M, McKay HA, Moreno LA (2010) Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone 46:294-305
Bonjour JP, Ammann P, Rizzoli R (1999) Importance of preclinical studies in the development of drugs for treatment of osteoporosis: a review related to the 1998 WHO guidelines. Osteoporos Int 9:379-393 (Pubitemid 29231729)
Muschler GF, Raut VP, Patterson TE, Wenke JC, Hollinger JO (2010) The design and use of animal models for translational research in bone tissue engineering and regenerative medicine. Tissue Eng Part B Rev 16:123-145
Ammann P (2009) Bone strength and ultrastructure. Osteoporos Int 20:1081-1083
Cashman KD (2002) Calcium intake, calcium bioavailability and bone health. Br J Nutr 87(Suppl 2):S169-S177 (Pubitemid 34685551)
Fairweather-Tait SJ, Teucher B (2002) Calcium bioavailability in relation to bone health. Int J Vitam Nutr Res 72:13-18 (Pubitemid 34186301)
Gueguen L, Pointillart A (2000) The bioavailability of dietary calcium. J Am Coll Nutr 19:119S-136S (Pubitemid 30185346)
Leeming DJ, Alexandersen P, Karsdal MA, Qvist P, Schaller S, Tanko LB (2006) An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol 62:781-792 (Pubitemid 44521426)
Civitelli R, Armamento-Villareal R, Napoli N (2009) Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporos Int 20:843-851
Brown JP, Albert C, Nassar BA, Adachi JD, Cole D, Davison KS, Dooley KC, Don-Wauchope A, Douville P, Hanley DA, Jamal SA, Josse R, Kaiser S, Krahn J, Krause R, Kremer R, Lepage R, Letendre E, Morin S, Ooi DS, Papaioaonnou A, Ste-Marie LG (2009) Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem 42:929-942
Vasikaran SD (2008) Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis. Crit Rev Clin Lab Sci 45:221-258 (Pubitemid 351544135)
Vasikaran SD, Glendenning P, Morris HA (2006) The role of biochemical markers of bone turnover in osteoporosis management in clinical practice. Clin Biochem Rev 27:119-121
Vasikaran SD, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JK (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22(2):391-420
Consensus development conference (1993) Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646-650
Lespessailles E, Chappard C, Bonnet N, Benhamou CL (2006) Imaging techniques for evaluating bone microarchitecture. Joint Bone Spine 73:254-261 (Pubitemid 44316566)
Brandi ML (2009) Microarchitecture, the key to bone quality. Rheumatol Oxf 48(Suppl 4):iv3-iv8
Hochberg MC (2006) Recommendations for measurement of bone mineral density and identifying persons to be treated for osteoporosis. Rheum Dis Clin North Am 32:681-689 (Pubitemid 46590098)
Seeman E (2007) Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy? Bone 41:308-317 (Pubitemid 47199158)
